Siliq (brodalumab) - Bausch Health, Leo Pharma, Kyowa Hakko Kirin
Brodalumab: Regulatory decision in Asia for psoriasis in 2020 (Kyowa Hakko Kirin Pharma) - Aug 2, 2019 - Q2 2019 Results 
Non-US regulatory
https://ir.kyowakirin.com/en/library/earnings.html
 
Aug 2, 2019
 
 
dd559ccb-9ae0-4cd6-9a45-9d240a2861d6.jpg